A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Carfilzomib Impurity 102 - Request Quote

Picture of Carfilzomib Impurity 102

Carfilzomib Impurity 102

SZ CAT No:SZ-C070120
CAS No
NA
Mol.F.
C40H59N5O8
Mol.Wt.
737.9
Inv. Status
Under QC Approval

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Carfilzomib Impurity 102 is chemically N-(1-((1,2-dihydroxy-2,6-dimethyl-3-oxoheptan-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-(2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide. Carfilzomib Impurity 102 is supplied with detailed characterization data compliant with regulatory guideline. Carfilzomib Impurity 102 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Carfilzomib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Carfilzomib Impurity 102

Purchase Carfilzomib Impurity 102

Carfilzomib Impurity 102 suppliers

Carfilzomib Impurity 102 manufacturers

Carfilzomib Impurity 102 price

Order Carfilzomib Impurity 102

Enquire Carfilzomib Impurity 102

Carfilzomib Impurity 102 cost

Carfilzomib Impurity 102 Supplier

Carfilzomib Impurity 102 Distributor

Carfilzomib Impurity 102 for Method Validation

Carfilzomib Reference Standard

Carfilzomib Impurity 102 for ANDA Filing

Carfilzomib Impurity 102 for Forced Degradation Studies

Carfilzomib Impurity 102 Identification Standards

Carfilzomib Impurity 102 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,